Allogeneic Mesenchymal Stem Cells for the Survivors of Ischemic Stroke Trial (ASSIST)

NCT04590118 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: it-hMSC
DRUG: Placebo

Sponsor

Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.

Collaborators

[object Object]